“Funny People” Movie Addresses Cancer Diagnosis

Frankly, I think Adam Sandler is best reserved for 14 year old boys. And my husband. That’s why I was so surprised when I found myself watching “Funny People,” and liking it. In it, Adam Sandler plays George Simmons, a blue comedian who finds out he has acute myeloid leukemia (AML).
When Simmons finds out the results, the AML has progressed so far that he requires experimental treatment that could help his body battle the leukemia. And, as he does so, he is forced to prepare himself to die and comes up against age-old questions about life – why he’s there, the value of material things, the nature of friendship, loneliness and more.

In terms of great movies, it wasn’t an award winner and probably shouldn’t have been. But a quiet movie that has the potential to make you think about your own life, it has great value. This isn’t “Bucket List,” and there’s no treks across the world to see the Seven Wonders. Instead, this movie focuses on the relationships that connect us, heal us, scar us, and define us. When I got done seeing it, it made me want to call a friend.
Be warned - the language and humor is rough, and I couldn’t let my teenager watch it. This movie is not for those easily offended.

Blog Category: 

More Articles

More Articles

Amazon.com is pleased to have the Lymphoma Information Network in the family of Amazon.com associates. We've agreed to ship items...

The question ought to be what are myelodysplastic syndromes (MDS), since this is a group of similar blood and bone marrow diseases that...

Merkel Cell Carcinoma (MCC) is a very rare and aggressive skin cancer that usually develops when a person is in his or her 70s. It is...

Radiation Therapy Topics

...

At some point, the Seattle biotech company Cell Therapeutics Inc (CTI) should earn an entry in the Guinness Book of World Records for utter and...

Site Beginnings

This site was started as Lymphoma Resource Page(s) in 1994. The site was designed to collect lymphoma...

Three papers appearing in the journal Blood and pointing towards a regulator-suppressor pill could offer hope to blood cancer...

The US Food and Drug Administration (FDA) has granted a third so-called Breakthrough Therapy Designation for the investigational oral...

The US Food and Drug Administration today has approved an expanded use of Imbruvica (ibrutinib) in patients with...

The U.S. Food and Drug Administration has announced that it has granted "Breakthrough Therapy Designation" for the investigational agent...

According to a new study published in the Proceedings of the National Academy of Sciences, a team from the University of California, San...

Pharmacyclics has announced that the company has submitted a New Drug Application (NDA) to the US Food and Drug Administration (FDA) for...

New research suggests that frontline radioimmunotherapy...

Gilead Sciences has announced results of the company's Phase II study of its investigational compound idelalisib, an oral inhibitor of...

Sitemap